Fiduciary Advisors Inc’s AbbVie ABBV Stock Holding History

Fiduciary Advisors Inc’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.3K	Buy	160 +10	+7%	+$2.15K	0.03%	67
2026 Q1	$32.6K	Hold	150	–	–	0.02%	71
2025 Q4	$34.3K	Hold	150	–	–	0.03%	69
2025 Q3	$34.7K	Hold	150	–	–	0.03%	60
2025 Q2	$27.8K	Hold	150	–	–	0.02%	63
2025 Q1	$31.4K	Sell	150 -12	-7%	-$2.33K	0.03%	59
2024 Q4	$28.8K	Buy	+162	New	+$29.8K	0.03%	61

Other funds holding ABBV

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

AAIS

ABN AMRO Investment Solutions Paris Cedex 008 $11.5B AUM 32.2% 1-Year Est. Return

Fiduciary Advisors Inc's ABBV Position: Q2 2026 in Review

Fiduciary Advisors Inc increased its AbbVie (ABBV) stake by 6.7% in Q2 2026, buying an estimated $2.15K and bringing the position to 160 shares worth $40.3K. The position accounts for 0.03% of the portfolio, ranked #67.

Fiduciary Advisors Inc first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. 1,496 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Fiduciary Advisors Inc held 160 shares of AbbVie worth $40.3K as of Q2 2026.
Fiduciary Advisors Inc bought 10 AbbVie shares in Q2 2026, an estimated $2.15K.
AbbVie made up 0.03% of Fiduciary Advisors Inc's portfolio in Q2 2026, its #67 holding.
Fiduciary Advisors Inc first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
1,496 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Fiduciary Advisors Inc's 13F filing for Q2 2026, filed 24 Jul 2026.